(Q40779596)

English

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

0 references

follicular lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Nicola Di Gaetano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Martino Introna

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Y Xiao

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Erba

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Bassan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Rambaldi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

114

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

800-809

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Control of the complement system.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Homologous and heterologous desensitization of proto-oncogene cfos expression in murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03014.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40779596&oldid=1561097217"